Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094529
Filing Date
2024-08-09
Accepted
2024-08-09 13:52:04
Documents
100
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q btmd-20240630.htm   iXBRL 10-Q 2950828
2 EX-10.2 btmd-ex10_2.htm EX-10.2 137062
3 EX-10.3 btmd-ex10_3.htm EX-10.3 105203
4 EX-10.5 btmd-ex10_5.htm EX-10.5 120238
5 EX-10.6 btmd-ex10_6.htm EX-10.6 90642
6 EX-31.1 btmd-ex31_1.htm EX-31.1 15540
7 EX-31.2 btmd-ex31_2.htm EX-31.2 16110
8 EX-32.1 btmd-ex32_1.htm EX-32.1 8778
9 EX-32.2 btmd-ex32_2.htm EX-32.2 9250
10 GRAPHIC img170578887_0.jpg GRAPHIC 3908
  Complete submission text file 0000950170-24-094529.txt   12523973

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT btmd-20240630.xsd EX-101.SCH 1721881
102 EXTRACTED XBRL INSTANCE DOCUMENT btmd-20240630_htm.xml XML 2199697
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40128 | Film No.: 241191840
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)